BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan W, Lim SG, Tan TM. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1. World J Gastroenterol 2015; 21(46): 13030-13041 [PMID: 26676187 DOI: 10.3748/wjg.v21.i46.13030]
URL: https://www.wjgnet.com/1948-5182/full/v21/i46/13030.htm
Number Citing Articles
1
Guochen Zhang, Junlan Wang, Ruilin Zheng, Beibei Song, Li Huang, Yujiang Liu, Yating Hao, Xiangdong Bai. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer CellsTechnology in Cancer Research & Treatment 2020; 19: 153303382092701 doi: 10.1177/1533033820927011
2
Xiaona Zhang, Xu Gong, Jinpeng Qiu, Yang Zhang, Fengyan Gong. MicroRNA-210 contributes to peripheral nerve regeneration through promoting the proliferation and migration of Schwann cellsExperimental and Therapeutic Medicine 2017; 14(4): 2809 doi: 10.3892/etm.2017.4869
3
Hamdy E. Abouzeid Ali, Rehab Abdel Hameed, Heba Effat, Emad K. Ahmed, Azza A. Atef, Sabry K. Sharawi, Mohamed Ali, Zakaria Y. Abd Elmageed, Abdel Hady Abdel Wahab. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2017; 41(4): e51 doi: 10.1016/j.clinre.2017.06.004
4
Zheng Fang, Shuai Yin, Ruochuan Sun, Shangxin Zhang, Min Fu, Youliang Wu, Tao Zhang, Junaid Khaliq, Yongxiang Li. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0708-6
5
Baoyong Wang, Hongwei Chen, Chunfen Zhang, Tian Yang, Qiaofei Zhao, Yifan Yan, Yu Zhang, Feng Xu. Effects ofhsa_circRBM23on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 ExpressionCancer Biotherapy and Radiopharmaceuticals 2018; 33(5): 194 doi: 10.1089/cbr.2017.2424
6
Shouyue Liu, Tao Jiang, Yingjie Zhong, Yin Yu. miR‐210 inhibits cell migration and invasion by targeting the brain‐derived neurotrophic factor in glioblastomaJournal of Cellular Biochemistry 2019; 120(7): 11375 doi: 10.1002/jcb.28414
7
Wenbing Sun, Shuqi Fu, Size Wu, Rong Tu, Diego Franco. Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4501454
8
Lóránd Váncza, Katalin Karászi, Bálint Péterfia, Lilla Turiák, Katalin Dezső, Anna Sebestyén, Andrea Reszegi, Gábor Petővári, András Kiss, Zsuzsanna Schaff, Kornélia Baghy, Ilona Kovalszky. SPOCK1 Promotes the Development of Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.819883
9
Philipp Felgendreff, Nathanael Raschzok, Kerstin Kunze, Annekatrin Leder, Steffen Lippert, Sergej Klunk, Hans-Michael Tautenhahn, Hans-Michael Hau, Rosa Bianca Schmuck, Anja Reutzel-Selke, Igor Maximilian Sauer, Michael Bartels, Mehmet Haluk Morgül. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinomaBiomarkers 2020; 25(1): 62 doi: 10.1080/1354750X.2019.1691267
10
Germana Zaccagnini, Simona Greco, Christine Voellenkle, Carlo Gaetano, Fabio Martelli. miR-210 hypoxamiR in Angiogenesis and DiabetesAntioxidants & Redox Signaling 2022; 36(10-12): 685 doi: 10.1089/ars.2021.0200
11
László Bányai, Maria Trexler, Krisztina Kerekes, Orsolya Csuka, László Patthy. Use of signals of positive and negative selection to distinguish cancer genes and passenger geneseLife 2021; 10 doi: 10.7554/eLife.59629
12
Wei Guo, Dong-Mei Shang, Jing-Hui Cao, Kaiyan Feng, Yi-Chun He, Yang Jiang, ShaoPeng Wang, Yu-Fei Gao. Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart AlgorithmBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6132436
13
Yuqiang Xu, Kuikui Ge, Junhao Lu, Jinjiang Huang, Wei Wei, Qingshan Huang. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2)Biomedicine & Pharmacotherapy 2017; 93: 334 doi: 10.1016/j.biopha.2017.06.047
14
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Daiming Fan, Liu Hong. Biological implications and clinical value of mir-210 in gastrointestinal cancerExpert Review of Gastroenterology & Hepatology 2017; 11(6): 539 doi: 10.1080/17474124.2017.1309281
15
Runglawan Silakit, Yingpinyapat Kitirat, Suyanee Thongchot, Watcharin Loilome, Anchalee Techasen, Piti Ungarreevittaya, Narong Khuntikeo, Puangrat Yongvanit, Ji Hye Yang, Nam Hee Kim, Jong In Yook, Nisana Namwat, Fabio Martelli. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cellsPLOS ONE 2018; 13(6): e0199827 doi: 10.1371/journal.pone.0199827
16
Risks With Use of Oral Propranolol for Infantile HemangiomaAAP Grand Rounds 2018; 40(3): 33 doi: 10.1542/gr.40-3-33
17
Jingcheng Wang, Yang Tian, Hui Chen, Hui Li, Shusen Zheng. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinomaMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.8871
18
Xudong Ren, Yu Zhou, Yunling Luo, Chaoqun Wang, Anna Pan, Yanqin Ju, Haoting Sun, Zhifei Lin, Beiyuan Hu, Guangzheng Sun, Wenwei Zhu, Liang Hong, Zhihua Kang. IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3pGastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/4589163